Related Experiment Video
Updated: Jul 27, 2025
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.4K
Cardiovascular aging: from cellular and molecular changes to therapeutic interventions
Angeliki Vakka1, Junco S Warren2, Konstantinos Drosatos1
1Metabolic Biology Laboratory, Cardiovascular Center, Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
The Journal of Cardiovascular Aging
|June 5, 2023
Summary
Cardiovascular aging involves structural and functional decline due to oxidative stress and inflammation. Research highlights cell signaling pathways and potential interventions like metformin and lifestyle changes for heart health.
Area of Science:
- Cardiovascular Science
- Aging Research
- Molecular Biology
Background:
- Cardiovascular aging leads to cardiac hypertrophy, diastolic dysfunction, fibrosis, arterial stiffness, and endothelial dysfunction.
- These age-related changes are driven by interconnected processes including oxidative stress, mitochondrial dysfunction, autophagy, inflammation, and telomere dysfunction.
Purpose of the Study:
- To review the complex mechanisms underlying cardiovascular aging.
- To identify key cell signaling pathways implicated in age-related cardiovascular deterioration.
- To explore potential therapeutic interventions for cardiovascular aging.
Main Methods:
- Literature review of recent advances in cardiovascular aging research.
- Analysis of cell signaling pathways involved in cardiovascular aging.
- Compilation of data on pharmacological and lifestyle interventions.
Main Results:
- Cardiovascular aging is characterized by multiple interconnected molecular and cellular dysfunctions.
- Numerous cell signaling pathways are identified as critical regulators of cardiovascular aging.
- Pharmacological agents (metformin, SGLT2 inhibitors, rapamycin, dasatinib, quercetin) and lifestyle modifications show promise.
Conclusions:
- Understanding the molecular basis of cardiovascular aging is crucial for developing effective interventions.
- Targeting specific cell signaling pathways may mitigate age-related cardiovascular decline.
- A combination of pharmacological and lifestyle approaches could offer comprehensive strategies for promoting cardiovascular health in aging populations.
Related Concept Videos
01:26Aging
90
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
90
01:19The Effect of Aging on Tissues
2.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.2K
01:26Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
01:29Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
01:30Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K